Huang Yuanyuan, Zhang Mingyi, Wang Jie, Xu Dake, Zhong Chao
Center for Materials Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; Cas Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Center for Materials Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; Cas Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; Shenyang National Laboratory for Materials Science, Northeastern University, Shenyang, China; Electrobiomaterials Institute, Key Laboratory for Anisotropy and Texture of Materials (Ministry of Education), Northeastern University, Shenyang, China.
Curr Opin Microbiol. 2022 Aug;68:102154. doi: 10.1016/j.mib.2022.102154. Epub 2022 May 11.
A new trend in biomaterials synthesis is harnessing the production of microorganisms, owing to the low cost and sustainability. Because microorganisms use DNA as a production code, it is possible for humans to reprogram these cells and thus build living factories for the production of biomaterials. Over the past decade, advances in genetic engineering have enabled the development of various intriguing biomaterials with useful properties, with commercially available biomaterials representing only a few of these. In this review, we discuss the common strategies for the production of bulk and commodity biogenic polymers, and highlight several notable approaches such as modular protein engineering and pathway optimization in achieving these goals. We finally investigate the available synthetic biology tools that allow engineering of living materials, and discuss how this emerging class of materials has expanded the application scope of biomaterials.
由于成本低且可持续,利用微生物生产成为生物材料合成的一种新趋势。因为微生物将DNA用作生产代码,人类有可能对这些细胞进行重新编程,从而构建用于生产生物材料的活体工厂。在过去十年中,基因工程的进展使得开发出各种具有有用特性的有趣生物材料成为可能,而市售生物材料只是其中的少数几种。在本综述中,我们讨论了生产大量和商品生物聚合物的常见策略,并强调了实现这些目标的几种显著方法,如模块化蛋白质工程和途径优化。我们最后研究了可用于工程化活体材料的合成生物学工具,并讨论了这类新兴材料如何扩展了生物材料的应用范围。